Hydroxychloroquine Market Report by Dosage Type (200 Mg, 300 Mg, 400 Mg, and Others), Distribution (Hospital Pharmacies, Retail Pharmacies, and Others), Application (Rheumatoid Arthritis, Lupus Erythematosus, Malaria, Coronavirus (COVID-19), and Others), Grade (USP Standards Grade, EP Standards Grade, Pharmaceutical Standards Grade, and Others), Route of Administration (Oral, Intravenous), and Region 2024-2032

Hydroxychloroquine Market Report by Dosage Type (200 Mg, 300 Mg, 400 Mg, and Others), Distribution (Hospital Pharmacies, Retail Pharmacies, and Others), Application (Rheumatoid Arthritis, Lupus Erythematosus, Malaria, Coronavirus (COVID-19), and Others), Grade (USP Standards Grade, EP Standards Grade, Pharmaceutical Standards Grade, and Others), Route of Administration (Oral, Intravenous), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112023A2266
Year End sale Buy Now

Market Overview:

The global hydroxychloroquine market size reached US$ 1.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.5 Billion by 2032, exhibiting a growth rate (CAGR) of 6.98% during 2024-2032. The growing need to reduce pain and swelling, rising prevalence of malaria, and wide availability through various distribution channels represent some of the key factors driving the market.

Report Attribute 
Key Statistics
Base Year
2023
Forecast Years
2024-2032
Historical Years
2018-2023
Market Size in 2023
US$ 1.4 Billion
Market Forecast in 2032
US$ 2.5 Billion
Market Growth Rate 2024-2032 6.98%


Hydroxychloroquine (C18H26ClN3O) refers to a disease-modifying anti-rheumatic drug (DMARD) that is designed to regulate the activity of the immune system. It is widely available in tablet form and different dosages capacity, such as 200, 300, and 400 mg. It is cost-effective and can be consumed as a part of combination therapy with any other drug. It has immunosuppressive, anti-autophagy, and antimalarial properties that destroy germs and bacteria and prevent several diseases. It can easily modify the underlying disease process, rather than only treating the symptoms among individuals, and assists in lowering the number of disease flares. Besides this, it aids in reducing the number of antigens cells in the skin and delays the absorption of ultraviolet (UV) light. As it is widely utilized to treat or prevent several health problems, such as rheumatoid arthritis, systemic lupus erythematosus (SLE), juvenile idiopathic arthritis (JIA), malaria, and coronavirus (covid-19) among individuals, the demand for C18H26ClN3O is rising across the globe.

Global Hydroxychloroquine Market

Hydroxychloroquine Market Trends:

At present, the increasing adoption of C18H26ClN3O due to the rising prevalence of malaria cases among the masses around the world represents one of the key factors supporting the growth of the market. Besides this, the growing demand for C18H26ClN3O, as it has fewer side effects with improved health results, is positively influencing the market. Additionally, the rising adoption of C18H26ClN3O, as it assists in reducing pain, swelling, and joint stiffness among individuals, is impelling the growth of the market. Apart from this, increasing number of various autoimmune diseases among the masses worldwide is propelling the growth of the market. In addition, the rising utilization of C18H26ClN3O to treat porphyria cutanea tarda wherein an individual suffer from a painful and blistering skin due to sensitivity to sunlight, is offering lucrative growth opportunities to industry investors. Moreover, governing agencies of various countries are developing healthcare infrastructure across the globe, which is offering a favorable market outlook. In line with this, the wide availability of C18H26ClN3O through online and offline pharmacy stores around the world is contributing to the growth of the market. Furthermore, the increasing demand for C18H26ClN3O, as it aids in decreasing disease flares among individuals, is bolstering the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global hydroxychloroquine market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on dosage type, distribution, application, grade and route of administration.

Dosage Type Insights:

  • 200 Mg
  • 300 Mg
  • 400 Mg
  • Others
     

The report has provided a detailed breakup and analysis of the hydroxychloroquine market based on the dosage type. This includes 200 mg, 300 mg, 400 mg, and others.

Distribution Insights:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others
     

A detailed breakup and analysis of the hydroxychloroquine market based on the distribution has also been provided in the report. This includes hospital pharmacies, retail pharmacies, and others. According to the report, hospital pharmacies accounted for the largest market share.

Application Insights:

  • Rheumatoid Arthritis
  • Lupus Erythematosus
  • Malaria
  • Coronavirus (COVID-19)
  • Others
     

A detailed breakup and analysis of the hydroxychloroquine market based on the application has also been provided in the report. This includes rheumatoid arthritis, lupus erythematosus, malaria, coronavirus (COVID-19), and others. According to the report, malaria accounted for the largest market share.

Grade Insights:

  • USP Standards Grade
  • EP Standards Grade
  • Pharmaceutical Standards Grade
  • Others
     

A detailed breakup and analysis of the hydroxychloroquine market based on the grade has also been provided in the report. This includes USP standards grade, EP standards grade, pharmaceutical standards grade, and others.

Route of Administration Insights:

  • Oral
  • Intravenous
     

A detailed breakup and analysis of the hydroxychloroquine market based on the route of administration has also been provided in the report. This includes oral and intravenous. According to the report, oral accounted for the largest market share.

Regional Insights:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others) was the largest market for hydroxychloroquine. Some of the factors driving the Asia Pacific hydroxychloroquine market included the growing demand for generic medications, favorable government initiatives, rising cases of malaria in the region, etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global hydroxychloroquine market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Amneal Pharmaceuticals Inc., Cipla Ltd., Ipca Laboratories Ltd., Laurus Labs, Lupin Limited, Mylan N.V., Prasco Laboratories, Dr. Reddy’s Laboratories Ltd., Sanofi S.A., Teva Pharmaceuticals USA Inc. (Teva Pharmaceutical Industries Ltd.), Torrent Pharmaceuticals Ltd., Zydus Lifesciences Limited, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Report Coverage:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Billion
Segment Coverage Dosage Type, Distribution, Application, Grade, Route of Administration, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Amneal Pharmaceuticals Inc., Cipla Ltd., Ipca Laboratories Ltd., Laurus Labs, Lupin Limited, Mylan N.V., Prasco Laboratories, Dr. Reddy’s Laboratories Ltd., Sanofi S.A., Teva Pharmaceuticals USA Inc. (Teva Pharmaceutical Industries Ltd.), Torrent Pharmaceuticals Ltd. and Zydus Lifesciences Limited
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


Key Questions Answered in This Report:

  • How has the global hydroxychloroquine market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global hydroxychloroquine market?
  • What is the impact of each driver, restraint, and opportunity on the global hydroxychloroquine market?
  • What are the key regional markets?
  • Which countries represent the most attractive hydroxychloroquine market?
  • What is the breakup of the market based on the dosage type?
  • Which is the most attractive dosage type in the hydroxychloroquine market?
  • What is the breakup of the market based on the distribution?
  • Which is the most attractive distribution in the hydroxychloroquine market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the hydroxychloroquine market?
  • What is the breakup of the market based on the grade?
  • Which is the most attractive grade in the hydroxychloroquine market?
  • What is the breakup of the market based on the route of administration?
  • Which is the most attractive route of administration in the hydroxychloroquine market?
  • What is the competitive structure of the global hydroxychloroquine market?
  • Who are the key players/companies in the global hydroxychloroquine market?

Key Benefits for Stakeholders:

  • IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the hydroxychloroquine market from 2018-2032.
  • The research study provides the latest information on the market drivers, challenges, and opportunities in the global hydroxychloroquine market.
  • The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
  • Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the hydroxychloroquine industry and its attractiveness.
  • Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Hydroxychloroquine Market Report by Dosage Type (200 Mg, 300 Mg, 400 Mg, and Others), Distribution (Hospital Pharmacies, Retail Pharmacies, and Others), Application (Rheumatoid Arthritis, Lupus Erythematosus, Malaria, Coronavirus (COVID-19), and Others), Grade (USP Standards Grade, EP Standards Grade, Pharmaceutical Standards Grade, and Others), Route of Administration (Oral, Intravenous), and Region 2024-2032
Purchase options Year End sale



Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More